- 询价
- 2025年09月29日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 年限：
3 years
- 物种来源：
人
- 是否是肿瘤细胞：
0
- 运输方式：
冻存运输
- 库存：
大量
- 组织来源：
peripheral blood; chronic myelogenous leukemia
- ATCC Number：
CRL-1567™
- 细胞形态：
淋巴样
- 生长状态：
悬浮生长
| Designations: | NALM-1 | ||
| Depositors: | J Minowada | ||
| Biosafety Level: | 1 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | suspension | ||
| Organism: | Homo sapiens | ||
| Morphology: | lymphoblast |
||
| Source: | Tissue: peripheral blood; chronic myelogenous leukemia | ||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Applications: | By means of a panel of specific xenoantisera, the NALM-1 cells were found to express a specific antigen of acute lymphoblastic leukemia and blast leukemia-associated antigen. Furthermore, normal T-cell or B-cell antigens, detectable by the antisera used in this study, were not found in the NALM-1 line. The cells exhibited no cell-surface receptors for sheep erythrocytes, IgG, or complement; neither cell-surface immunoglobulins nor cytoplasmic immunoglobulin were observed. |
||
| DNA Profile (STR): | Amelogenin: X CSF1PO: 10,12 D13S317: 11,12 D16S539: 11,15 D5S818: 11 THO1: 7,9 TPOX: 9,11 vWA: 15,17 |
||
| Cytogenetic Analysis: | Contains Philadelphia chromosome (Ph1) [ Pubmed: 302341, 15588857]. | ||
| Age: | 3 years | ||
| Gender: | female | ||
| Comments: | A permanent hematopoietic cell line, designated NALM-1, was established from the peripheral blood of a patient who was in blastic crisis of Ph1-positive chronic myleocytic leukemia. By means of a panel of specific xenoantisera, the NALM-1 cells were found to express a specific antigen of acute lymphoblastic leukemia and blast leukemia-associated antigen. The cells exhibited no cell-surface receptors for sheep erythrocytes, IgG, or complement; neither cell-surface immunoglobulins nor cytoplasmic immunoglobulin were observed. Furthermore, normal T-cell or B-cell antigens, detectable by the antisera used in this study, were not found in the NALM-1 line. [Pubmed: 301573]. | ||
| Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%. Temperature: 37.0°C |
||
| Subculturing: | Protocol: Cultures can be maintained by addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 x 10(5) viable cells/ml. Maintain cultures at a cell concentration between 1-2 X 10(5) and 1 X 10(6) cells/ml. Do not allow the cell concentration to exceed 1 X 10(6) cells/ml. | ||
| Preservation: | Freeze medium: complete growth medium 95%,DMSO 5% Storage temperature: liquid nitrogen vapor phase |
||
| References: | 16172887: Minawada J, et al. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J. Natl. Cancer Inst. 59(1): 83-87, 1977. PubMed: 301573. 16172888: Sonta SI, et al. Cytogenetic study of a new Ph1-positive cell line (NALM-1). J. Natl. Cancer Inst. 59(3): 833-837, 1977. PubMed: 302341. 16172889: Pelz AF. Re-analysis of the cell line NALM-1 karyotype by GTG-banding, spectral karyotyping, and whole chromosome painting. Cancer Genet. Cytogenet. 156(1): 59-61, 2005. PubMed: 15588857. |
||
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Highly Proficient Gene Targeting by Homologous Recombination in the Human Pre-B Cell Line Nalm-6
for analyzing the functions of human genes in greater detail. Although the frequency of gene targeting is typically very low in human cultured cells, we have recently shown that a human precursor B cell line, Nalm-6, exceptionally allows for high-efficiency gene
CAR-T 攻克实体瘤又出新招！超声「遥控」细胞靶向治疗癌症
19 阳性肿瘤细胞的嵌合抗原受体（CD19CAR）。接下来他们研究了热诱导表达的 CD19CAR 在细胞中的功能。将热诱导工程化 Jurkat 细胞（即热诱导的 CD19CAR-T 细胞）与表达 CD19 的 Nalm-6 肿瘤细胞共培养 24 小时，他们发现加热诱导了 T 细胞的早期活化。细胞毒性试验显示热诱导 T 细胞的肿瘤细胞毒性随着 E : T（effector-to-target）比率的增加而增加，证实了热诱导的 CAR-T 细胞获得了杀伤癌细胞的能力。图片来源：Nature
期间不需要进行任何的操作，实验结束后通过软件分析的Total integrated GFP intensity进行杀伤活性分析。 针对Nalm6靶细胞CAR-T以及过表达c-Jun的CAR-T细胞都表现出很好的杀伤活性，但是在低表达靶抗原的Nalm6-F靶细胞中，过表达c-Jun的CAR-T细胞表现出了更好的杀伤活性。 并且在低的效靶比的情况下，过表达c-Jun的CAR-T细胞依然可以维持更好的杀伤活性。并且在后期的小鼠体内肿瘤模型也显示了类似的结果。该文章利用在体
技术资料暂无技术资料 索取技术资料
